News

Xenon and Roche have entered into a worldwide research and license agreement to jointly research protein-based inhibitors of hemojuvelin (HJV). In addition to the research and license agreement

The research offers evidence of a potential drug target in a flu protein called nucleoprotein, or NP. The nucleoprotein is found in strains of the virus that cause

The company is conducting an investigation to determine the root cause of this failure and believes that it is likely related to the higher than expected moisture content

Researchers said the study was the largest to evaluate Gleevec in chronic myeloid leukemia (CML). The five-year overall survival of CML patients who received Gleevec as initial therapy

The drug is being developed in partnership with Schering-Plough. The company said it expected trials to resume by mid-January and believes that the delay will not affect the

Immune believes the agreement will provide it with a solid financial basis beyond the next three years to develop other programs at full speed. Beta-amyloid constitutes an important

While the Roskamp Institute’s primary focus is on Alzheimer’s disease, Roskamp researchers have a significant interest in multiple sclerosis (MS). This is due to findings that suggest there

The FDA is holding a two-day advisory committee session to examine the safety of stents, a medical device inserted into damaged arteries which are designed to prop open

The finding offers clinicians a way to identify patients who are likely to develop diarrhea as a side effect from taking these drugs, the researchers said. The discovery